Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases

NCT03325166 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Lung Carcinoma Metastatic in the Brain
Stage IV Lung Non-Small Cell Cancer AJCC v7

Interventions

DRUG: Ferumoxytol
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Pembrolizumab

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]
[object Object]